Anthera Pharmaceuticals, Inc. (ANTH)
OTCMKTS
· Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Jan 17, 2025, 4:00 PM EST
Anthera Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | 2012 - 2008 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '18 Mar 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | 2012 - 2008 |
| Revenue | - | - | 0.15 | 3.19 | - | - | Upgrade
|
| Revenue Growth (YoY) | - | - | -95.45% | - | - | - | Upgrade
|
| Cost of Revenue | 28.26 | 28.49 | 46.25 | 30.86 | 21.84 | 21.68 | Upgrade
|
| Gross Profit | -28.26 | -28.49 | -46.11 | -27.68 | -21.84 | -21.68 | Upgrade
|
| Selling, General & Admin | 8.54 | 7.94 | 11.07 | 7.57 | 6.62 | 6.56 | Upgrade
|
| Operating Expenses | 8.54 | 7.94 | 11.07 | 7.57 | 6.62 | 6.56 | Upgrade
|
| Operating Income | -36.8 | -36.43 | -57.18 | -35.24 | -28.46 | -28.25 | Upgrade
|
| Interest Expense | - | - | - | - | -1.05 | -2.6 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | - | - | -0.02 | Upgrade
|
| Other Non Operating Income (Expenses) | 13.41 | 10.16 | 1.65 | 0.02 | -0.1 | - | Upgrade
|
| EBT Excluding Unusual Items | -23.39 | -26.27 | -55.52 | -35.22 | -29.6 | -30.86 | Upgrade
|
| Other Unusual Items | - | -0.6 | - | - | - | - | Upgrade
|
| Pretax Income | -23.39 | -26.87 | -55.52 | -35.22 | -29.6 | -30.86 | Upgrade
|
| Net Income | -23.39 | -26.87 | -55.52 | -35.22 | -29.6 | -30.86 | Upgrade
|
| Preferred Dividends & Other Adjustments | 1.54 | 2.5 | 10.91 | - | - | - | Upgrade
|
| Net Income to Common | -24.93 | -29.38 | -66.44 | -35.22 | -29.6 | -30.86 | Upgrade
|
| Shares Outstanding (Basic) | 14 | 10 | 5 | 4 | 3 | 2 | Upgrade
|
| Shares Outstanding (Diluted) | 14 | 10 | 5 | 4 | 3 | 2 | Upgrade
|
| Shares Change (YoY) | 152.23% | 99.05% | 15.94% | 63.62% | 19.21% | 152.82% | Upgrade
|
| EPS (Basic) | -1.76 | -2.86 | -12.87 | -7.91 | -10.88 | -13.52 | Upgrade
|
| EPS (Diluted) | -1.76 | -2.86 | -12.87 | -7.91 | -10.88 | -13.52 | Upgrade
|
| Free Cash Flow | -31.95 | -36.9 | -49.69 | -30.99 | -25.6 | -31.93 | Upgrade
|
| Free Cash Flow Per Share | -2.26 | -3.59 | -9.62 | -6.96 | -9.41 | -13.98 | Upgrade
|
| Operating Margin | - | - | -39432.41% | -1106.53% | - | - | Upgrade
|
| Profit Margin | - | - | -45818.62% | -1105.81% | - | - | Upgrade
|
| Free Cash Flow Margin | - | - | -34265.52% | -972.90% | - | - | Upgrade
|
| EBITDA | -36.4 | -36.15 | -56.91 | -34.96 | -28.12 | -27.89 | Upgrade
|
| D&A For EBITDA | 0.4 | 0.28 | 0.27 | 0.29 | 0.34 | 0.35 | Upgrade
|
| EBIT | -36.8 | -36.43 | -57.18 | -35.24 | -28.46 | -28.25 | Upgrade
|
| Revenue as Reported | - | - | 0.15 | 3.19 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.